THE HEALTHCARE & SCIENCE BUSINESS OF THOMSON REUTERSACCELERATING R&D and INNOVATION

Keith MacGregor

Executive Vice PresidentNovember 12, 2010

THOMSON REUTERS

Sales & Trading

EnterpriseInvestment & Advisory

Media LegalTax &

AccountingHealthcare& Science

MARKETS DIVISION PROFESSIONAL DIVISION

Information trading for buy/sell side

Information/software for capital markets

Decision support, portfolio mgr, investment

Global news services

Legal, professional & government, professionals

Researchers, scientists, healthcare professionals,

Tax, accounting, compliance, professional &

Thomson Reuters at a glance: 2009 Revenue: US $12.9billion

Employees: 50,000

Operations: 100 countries

banking academic & government

government

2

Intelligent information to better manage the cost and quality of healthcare and accelerate scientific research

THE HEALTHCARE & SCIENCE BUSINESS OF THOMSON REUTERS

3

accelerate scientific research and innovation.

INTELLIGENT INFORMATION

Human intelligence, industry expertise, and innovative technology to provide decision makers with the knowledge to act

DIFFERENTIATED OFFERINGS

Unique, derived content, added-value capabilities, and powerful comprehensiveness make us a valued partner

DATA YOU CAN TRUST

We are committed to delivering reliable data of the highest quality – with ‘round-the-clock support, whenever you may need us

THOMSON REUTERS OPERATING PRINCIPLES

4

BREADTH AND DEPTH

Widely recognized as offering the broadest coverage of data across the globe

INDEPENDENT & OBJECTIVE QUALITY

Our editorial standards are unparalleled in the industry, providing you with only the very best information for confident decisions

Our focus is providing you with only the highest caliber data – free from bias – to give you a trusted resource of intelligent information

SCIENCE MARKETS

• IP SOLUTIONS Accelerating innovation in high tech industries, including engineering, automotive and aerospace

• SCIENTIFIC & SCHOLARLY RESEARCH Accelerating research at more than 5,000 research institutions, including national and regional consortia

• LIFE SCIENCES Accelerating discovery in 98 of the top 100 pharmaceutical companies

OUR PURPOSE : Accelerate research, discovery and innovation

Serving needs of researchers for quality, authoritative and timely information

– Discovery and research assessment tools for scientists to accelerate and optimize their research

– Comprehensive intellectual property research and management solutionssolutions

• Accelerate innovation while minimizing risk

• Gain competitive advantage with actionable intelligence

• Maximize R&D investments

– Drug discovery and support information tools for every stage of the drug development life cycle helping to get to market faster

• We create the research platforms and services of the future that will power our customers toward business and personal success

.6

SCIENTIFIC & SCHOLARLY RESEARCH

COMPETITION FOR RESEARCH FUNDING IS FIERCE ACROSS THE

7

FIERCE ACROSS THE GLOBE, WE’VE GOT THE TOOLS TO HELP YOU SUCCEED.

LIFE SCIENCES

WITH AN ESTIMATED COST OF $500 MILLION* TO BRING A DRUG TO

8

TO BRING A DRUG TO MARKET, EVERY DECISION COUNTS.

*The Goodwyn Institutional Review Board, Ltd.

Powering the Intellectual Property Lifecycle with the world’s most comprehensive resources…

THOMSON REUTERS IP SOLUTIONS

PATENTS &STANDARDS

INTELLIGENT INFORMATION

ADVANCED TOOLS & ANALYTICS

EXPERT IP SERVICES

TRADEMARKSSTANDARDS

9

OUR APPROACH

• Understand customer’s workflow & work done +/- 3 minutes from our tools

SAMPLE WORKFLOW

minutes from our tools

• Develop strengths that address needs at each step prior and after interaction with our solutions

Online Research

Meeting &Discussion

MeetingPreparation

Document Sharing

Commenting& Annotation

10

SUPPORTING THE IP LIFECYCLE

• Drive innovation

• Protect intellectual assets

• Create maximum

Filing Strategy

Ma

rke

t

Aw

are

ne

ss

• Create maximum value from their ideas

11

THE SPEED OF INNOVATION

As the pace of innovation increases, companies are looking for new ways to decrease their time to market.

Stimulate new product ideas

Make smart build vs. buy decisions

Stimulate new product ideas

Clear trademarks for use more quickly

12

THANK YOU